Crimi C., Noto A., Madotto F., Ippolito M., Nolasco S., Campisi R., De Vuono S., Fiorentino G., Pantazopoulos I., Chalkias A., Libra A., Mattei A., Scala R., Clini E.M., Ergan B., Lujan M., Winck J.C., Giarratano A., Carlucci A., Gregoretti C., Groff P., Cortegiani A. (2022)
Rationale: In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO compared with conventional oxygen therapy (COT) ...